Atlas Trials

Fruquintinib Plus Camrelizumab and HAIC in the Treatment of Non-MSI-H Advanced Colorectal Cancer

Clinical trial NCT06423937 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06423937
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2024-05-01
Primary completion
2026-07-01
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.